Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bruker Releases ONET Software
Thursday, December 18, 2014
New networking software for administration of FT-NIR spectrometer networks.

ONET Software Released
Wednesday, December 17, 2014
Bruker releases ONET Software for administration of FT-NIR spectrometer networks.

Rigaku Publishes New Method for Silicate Rock Analysis
Friday, December 12, 2014
Analysis by fusion using Rigaku ZSX Primus III+ WDXRF.

WITec Refreshes its Website www.witec.de
Tuesday, December 09, 2014
The webpage includes new features to broaden the spectrum of the website.

BioTek Introduces Cytation™ 5 Cell Imager at ASCB 2014
Thursday, December 04, 2014
ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania.

Limited Time Sale from Bibby Scientific
Thursday, December 04, 2014
Web Shop offers savings of up to 15% on all laboratory equipment.

Rigaku Publishes New Application Report
Thursday, December 04, 2014
New application report for quality and process control of iron ore products by pressed powder method.

A New Tool for Monitoring Pharmaceutical Freeze Drying
Wednesday, December 03, 2014
A new white paper examines the benefits of applying Tunable Diode Laser Absorption Spectroscopy for monitoring pharmaceutical freeze drying.

Morphologi G3-ID Accelerates Environmental Particle Research At Southern Cross University, Australia
Thursday, November 27, 2014
The Morphologi G3-ID is helping users understand the composition and behavior of natural particles within the environment.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 541
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn